A New Look At The Most Innovative Pharma Companies (And Whether They Are Sustainable) -- Part I

Measuring pharma innovation isn?t easy. One typically counts new drugs approved, but that only gauges quantity not quality. Various attempts at assessing quality have been made using such criteria as new modes of action (first-in-class); therapeutic need (orphan drugs); medical value (expert panels); or improvement over the standard of care

from Forbes - Leadership http://ift.tt/1Rp3xp5